Tumor Necrosis Factor α-Gene Therapy for an Established Murine Melanoma Using RGD (Arg-Gly-Asp) Fiber-mutant Adenovirus Vectors

• OKADA Yuka

  Department Pharmaceutics, School of Pharmaceutical Sciences, Mugogawa Women's University

• OKADA Naoki

  Department of Biophamaceutics, Kyoto Pharmaceutical University

• NAKAGAWA Shinsaku

  Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University

• MIZUGUCHI Hiroyuki

  Division of Biological Chemistry and Biologicals, National Institude of Health Sciences

• TAKAHASHI Koichi

  Department Pharmaceutics, School of Pharmaceutical Sciences, Mugogawa Women's University

• MIZUNO Nobuyasu

  Department Pharmaceutics, School of Pharmaceutical Sciences, Mugogawa Women's University

• FUJITA Takuya

  Department of Biophamaceutics, Kyoto Pharmaceutical University

• YAMAMOTO Akira

  Department of Biophamaceutics, Kyoto Pharmaceutical University

• HAYAKAWA Takao

  Division of Biological Chemistry and Biologicals, National Institude of Health Sciences

• MAYUMI Tadanori

  Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University

収録刊行物

• Japanese journal of cancer research : gann

  Japanese journal of cancer research : gann 93 (4), 436-444, 2002-04-30

キーワード

• Adenovirus vector
• Fiber-mutant
• Melanoma
• Tumor necrosis factor α
• Gene therpy

詳細情報

• CRID: 1571135649744507904
• NII論文ID: 10009550188
• NII書誌ID: AA00690844
• ISSN: 09105050
• Web Site: https://search.jamas.or.jp/link/ui/2002220513
• 本文言語コード: en
• データソース種別:
  • CiNii Articles